CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- SC 13D/A Stake Beneficial Ownership Report
- PRRN14A Other PRRN14A
- 4 Insider Changes in Ownership
- PRER14A Other PRER14A
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
Page 90 of 137 · 2,721 filings